Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Lorraine (Lori) Choi, MD, is a vascular surgeon in the Department of Vascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute, practicing at Cleveland Clinic main campus, Fairview Hospital, Cleveland Clinic Lorain Family Health Center and Chestnut Commons. She is board certified in general surgery and vascular surgery.
Dr. Choi received her B.A. from Duke University, earning Graduation with Distinction honors after completing a thesis on comparative international social policy. She received her medical degree from SUNY Downstate, Brooklyn, N.Y., following a post-baccalaureate premedical program at Columbia University, New York. While enrolled in this program, she also conducted basic science and clinical research at Columbia in the Division of Cardiovascular Surgery, earning the American Society of Artificial Implant Organs Willem J Kolff Young Investigator Award.
Dr. Choi served a residency in general surgery, followed by a residency in vascular surgery, both at Baylor College of Medicine, Houston, Texas. She was appointed as assistant professor to the University of Texas Medical Branch in Galveston, Texas in 2010 and was named to Texas Monthly's list of Rising Star physicians in 2013. She was appointed to the medical staff at Cleveland Clinic in 2013.
Dr. Choi has published numerous scientific papers and abstracts in vascular surgery journals and six medical textbook chapters. She has been an invited lecturer at nearly two dozen medical and scientific symposia and conferences across the United States. She is a member of the American College of Surgeons, the Society for Vascular Surgery and the Peripheral Vascular Surgery Society.
An avid exercise advocate, Dr. Choi has completed four New York Marathons and the Paris Marathon. She climbed Mt. Kilimanjaro via the Umbwe route, considered the most difficult non-technical approach to the summit.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/14/2014, Dr. Choi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.